Haemoglobin as a biomarker for clinical outcomes in chronic obstructive pulmonary disease
In COPD, anaemia is associated with increased morbidity, but the relationship between haemoglobin over its entire observed range and morbidity is poorly understood. Such an understanding could guide future therapeutic targeting of haemoglobin in COPD management. Leveraging the COPDGene study, we con...
Main Authors: | Aparna Balasubramanian, Robert J. Henderson, Nirupama Putcha, Ashraf Fawzy, Sarath Raju, Nadia N. Hansel, Neil R. MacIntyre, Robert L. Jensen, Gregory L. Kinney, William W. Stringer, Craig P. Hersh, Russell P. Bowler, Richard Casaburi, MeiLan K. Han, Janos Porszasz, Barry J. Make, Meredith C. McCormack, Robert A. Wise |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2021-07-01
|
Series: | ERJ Open Research |
Online Access: | http://openres.ersjournals.com/content/7/3/00068-2021.full |
Similar Items
-
Metformin use and respiratory outcomes in asthma-COPD overlap
by: Tianshi David Wu, et al.
Published: (2021-02-01) -
Association of thrombocytosis with COPD morbidity: the SPIROMICS and COPDGene cohorts
by: Ashraf Fawzy, et al.
Published: (2018-01-01) -
Omega-3 fatty acid intake and prevalent respiratory symptoms among U.S. adults with COPD
by: Chantal M. Lemoine S, et al.
Published: (2019-05-01) -
Pirates of the haemoglobin
by: Daniel Akinbosede, et al.
Published: (2022-02-01) -
Identifying a Heart Rate Recovery Criterion After a 6-Minute Walk Test in COPD
by: Zhao D, et al.
Published: (2021-09-01)